Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren? Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren? Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  As the Asia Thu morning start, we got news that have taken Equity Futures from green to red, with S&P futures currently down -0.30% on the news that we have potentially c. +15,000 new cases found in the province of Hubei - due to revised testing methods. This would take the confirmed cases to 60,000, which is on track to get to the 7 figures that we have been extrapolating on, since the 2019-nCoV now formally called Covid-19 kicked off. We also check in on US politics - put a fork in Biden! And see some central bankers comment on the virus as well as China stimulus.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon:+15K New Virus Cases + Put a fork in Biden & perhaps also Warren?


US Elections Checks in & Other Thoughts…

  • Bernie took NH, with Buttigieg close on his heels… As has been flagged to KVP (& believe we mentioned that IO & NH are very white states), Buttigieg base seems to be progressive, wealthy white folks, with actually very little traction on millennials despite at 38 him being much younger than the rest of the field. Millennials love ‘The Bern’. Klobuchar likely also took some wind out of Buttigieg sales (lucky for Sanders), yet she came in above Warren.
  • Unless Bernie stumbles any time soon (Unlikely), Warren is likely done – some massive time decay on that vehicle. Buttigieg & Klobuchar are likely going to struggle again the non-white base, as well as the less wealthy… stay tuned.
  • Meanwhile markets don’t really seem to care on any risk of a Sanders nomination – whether that’s because its priced correctly (i.e. he has not chance), its too early in the cycle & is not dominating enough, Trump has it in the bag, etc… too early to tell.


Covid-19 Update Thu Asia Mrn 12 Feb & Thoughts…


Quick update & thoughts on the Virus since the Yest’s check in:

  • As of this Wed 13 Asia morning, the China figures we are getting are at c. 45,200 confirmed cases, +1120 deaths & +5,150 recovered. So suggesting a considerable slowdown in confirmed cases in China & big uptick in those recovering.   
  • However a breaking news headline suggest that we may need to add up to +15,000 new cases stemming from the province of Hubei (60m people), given new methods used to test & screen for the coronavirus
  • This has sent S&P futures from positive territory to c. -0.40% to -0.50% lower this early morning Asia. If this is true, that would take confirmed cases in China to +60,000. As the Macro Dragon have conservatively stipulated before, given the population & seasonal dynamics of China – we likely get into the 6 figures before the Covid-19 is fully contained. And again 60,000 in a province of 60m (funnily enough the number of Americans infected with the H1N1 swine flu virus that broke out in the US in 2009), is only 0.10%.
  • One last point, a lot of countries are starting to put restrictions on travel to places like Singapore – this again is the paradox of circles of silence (just because the data is not there, does not mean there is no data). What people should be instead thinking is, if Singapore with its incredible experience, resources & organization honed through SARs has found these 50 cases, what is the “REAL” case count in other countries? i.e. Indonesia with 230m, Thailand with 70m, all whom also do a tremendous amount of business & travel with China.
  • Obviously an element of this is political – you have to be seen to be doing something, regardless of whether that action is actually fruitful or futile.
  • BoC’s Poloz is saying to early to really process the effects of the virus. And RBA’s Lowe point out that China has indicated that they will stimulate which should be good for the Australian economy. You have to wonder whether we could see an RBA similar to RBNZ o/n which did not cut rates as per expectations, yet seemed to signal that there would be no cuts in 2020 – sending the kiwi higher against crosses, there could be quite a bit of juice left here over the year (i.e. get to the other side of CH data gaining).

Outside of China the countries with confirmed cases over 10 are:

  • Japan 202 (174 from the cruise ship)
  • Hong Kong 50 (+1)
  • Singapore 50 (+3)
  • Thailand 33 (+1)
  • South Korea 28
  • Taiwan 18
  • Malaysia 18
  • Germany 16
  • Australia 15
  • Vietnam 15
  • United States 13 (+1)
  • France 11
  • Macau 10



      Have a fantastic, gratitude & abundant filled close to the wk everyone, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us.  




      Some Anchor Pieces from #SaxoStrats:


      Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

      The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

      Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

      To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

      None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

      Please read our disclaimers:
      - Full Disclaimer (
      - Analysis Disclaimer (
      - Notification on Non-Independent Investment Research (

      Saxo Capital Markets (Australia) Limited
      Suite 1, Level 14, 9 Castlereagh St
      Sydney NSW 2000

      Contact Saxo

      Select region


      The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

      Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

      Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

      Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

      The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

      Please click here to view our full disclaimer.